Bookmark

Add to MyYahoo RSS

Albany Molecular Research News

News on Albany Molecular Research (Ticker: AMRI) continually updated from thousands of sources around the net.

Tuesday Aug 26 | BioSpace

Albany Molecular Research, Inc. (AMRI) CEO To Present At The Morgan...

A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://www.amriglobal.com/investor_relations/AMRI_Webcast_Archive_56_pg.htm .

Comment?

Related Topix: Biotech, Healthcare Industry

Mon Aug 18, 2014

AmericanBankingNews.com

Insider Selling: Michael M. Nolan Sells 10,000 Shares of Albany Molecular Research Stock

Albany Molecular Research CFO Michael M. Nolan unloaded 10,000 shares of Albany Molecular Research stock in a transaction dated Thursday, August 14th.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising, Stanley

Wed Aug 13, 2014

AmericanBankingNews.com

Albany Molecular Research Director Sells $379,800 in Stock

Albany Molecular Research Director Ambra Thomas E. Phd D sold 20,000 shares of the company's stock in a transaction dated Monday, August 11th.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising, Stanley

AmericanBankingNews.com

Albany Molecular Research SVP Lori M. Henderson Sells 30,000 Shares

Albany Molecular Research SVP Lori M. Henderson sold 30,000 shares of the stock on the open market in a transaction dated Tuesday, August 12th.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising

Tue Aug 12, 2014

AmericanBankingNews.com

Insider Selling: Steven R. Hagen Unloads 10,797 Shares of Albany Molecular Research Stock

Albany Molecular Research SVP Steven R. Hagen unloaded 10,797 shares of the stock in a transaction that occurred on Friday, August 8th.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising, Stanley

AmericanBankingNews.com

Albany Molecular Research Downgraded to "Neutral" at Zacks

They currently have a $23.70 price target on the stock. Zacks 's price target would indicate a potential upside of 24.47% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising, Securities and Exchange Commission, Corporate / Securities Law, Law

Fri Aug 08, 2014

Business Journal

Regeneron, AMRI find sweet spot as revenues rise

In business the best strategy often involves finding the right size, whether counting employees, making investments or opening new facilities.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, East Greenbush, NY

Wed Aug 06, 2014

Albany Times Union

AMRI co-founder on pharmacy school's board

Thomas D'Ambra, who cofounded Albany Molecular Research Inc., has been appointed to the board of trustees at Albany College of Pharmacy and Health Sciences.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Albany College of Pharmacy, Albany, NY

Drug Researcher

Injectables outsourcing growing despite pharma M&A, says AMRI

Sterile injectables returning in-house? Not so says AMRI who has entered the sector through the acquisition of CMO Oso Bio Big Pharma is still reliant on CMOs despite talk of returning in-house, says AMRI, which has launched into the top ten manufacturers in the US injectables sector following its recent acquisition.

Comment?

Related Topix: Outsourcing, Biotech, Medicine, Healthcare Industry, Albuquerque, NM, Food and Drug Administration

Tue Aug 05, 2014

AmericanBankingNews.com

Albany Molecular Research Trading Up 8.5% Following Earnings Beat

Albany Molecular Research 's share price was up 8.5% during trading on Tuesday following a better than expected earnings announcement, ARN reports.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising, Stanley

BioSpace

Albany Molecular Research, Inc. (AMRI) Announces Second Quarter 2014 Results

Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures, which exclude certain items detailed later in this press release under the heading "Non-GAAP Adjustment Items."

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Aug 04, 2014

Business Journal

Catch up on two companies shaping Albany, New York's economy

This is a big week for news on the future of nearly 1,600 jobs at regional operations of Albany Molecular Research Inc. and Regeneron Pharmaceuticals Inc. This is a big week for news on the future of nearly 1,600 jobs at regional operations of Regeneron Pharmaceuticals Inc. The two drug-development companies are expected to release earnings reports ... (more)

Comment?

Related Topix: Albany, NY, Biotech, Medicine, Healthcare Industry, Regeneron Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••